LLC0424
Product Specifications
SKU
C04956-1mg
Target
NSD
Applications
Epigenetics
Additionnal Information
YJ9069 is a potent, selective and orally bioavailable PROTAC degrader of CDK12/CDK13. It inhibits proliferation in prostate cancer cells by inducing gene-length-dependent transcriptional elongation defects, leading to DNA damage, cell-cycle arrest, and significant tumor growth suppression in vivo.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
207875-ML550 100 µL
SERCA1 (ATP2A1, ATPase, Ca++ transporting, Cardiac Muscle, Fast Twitch 1, ATP2A, OTTHUMP00000162562, SR Ca (2+) -ATPase 1, Calcium pump 1, Calcium-transporting ATPase sarcoplasmic reticulum Type, Fast Twitch skeletal Muscle isoform, Endoplasmic reticulum class 1/2 Ca (2+) ATPase, Sarcoplasmic/endoplasm) (MaxLight 550)
Sign In for Pricing
View Details 
MBS7089531-01 0.05 mg (E-Coli)
Recombinant Human Uncharacterized protein C2orf82 (C2orf82) , partial
Sign In for Pricing
View Details MBS7089531-02 0.2 mg (E-Coli)
Recombinant Human Uncharacterized protein C2orf82 (C2orf82) , partial
Sign In for Pricing
View Details MBS7089531-03 0.05 mg (Yeast)
Recombinant Human Uncharacterized protein C2orf82 (C2orf82) , partial
Sign In for Pricing
View Details